z-logo
Premium
Racial differences in cellular composition of benign prostatic hyperplasia
Author(s) -
Aoki Yoshitaka,
Arai Yoichi,
Maeda Hiroshi,
Okubo Kazutoshi,
Shinohara Katsuto
Publication year - 2001
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.10019
Subject(s) - prostate , hyperplasia , stromal cell , medicine , prostate biopsy , prostate specific antigen , prostate cancer , biopsy , lumen (anatomy) , composition (language) , urology , endocrinology , cancer , linguistics , philosophy
Background The present study was designed to compare the cellular composition of benign prostatic hyperplasia (BPH) in Caucasian‐American (CA), African‐American (AA), and Japanese (JP) men. Methods Biopsy specimens of the prostate were obtained from 15 men of each racial group with a prostate‐specific antigen (PSA) of 4.1–10.0 ng/mL. The stained cores were quantitatively analyzed for the percentage of the area with different cellular composition (stroma (S), epithelium (E), epithelial lumen (L), and glandular component (E + L = G)), using computer‐assisted color imaging. Results The mean percent area density of S, E, and L in the prostate of CA men was 84.2, 12.1, and 3.8%, respectively; for AA, 84.4, 12.4, and 3.2%; for JP, 77.4, 15.2, and 7.5%. The S/E ratio is significantly lower in JP than in CA men. The S/G ratio is significantly lower in JP than in CA and AA men. Overall, JP contained more glandular lumen and less stromal component than that of CA and AA. CA and AA showed no significant difference in cellular composition. Conclusions The present study demonstrated the differences in cellular composition of BPH among the three races. This cellular composition divergence may account for previously observed racial differences in PSA, PSA density, and the incidence of clinical BPH. Prostate 49:243–250, 2001. © 2001 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here